Replies to post #233 on Trevena Inc (TRVN)

[Topgun21]

I have joined this party here today!
Great price and looking forward to a very bright future for TRVN!
Quite frankly, this looks like this will replace Morphine..... Just saying based on the EXCELLENT DD here with oliceridine!

Smart company and smart management that will bring positive changes to this multi billion dollar market!
Proud TRVN owner!!

Go TRVN, and Thanks for the cheap shares whoever sold them today!!??

[Topgun21]

Oliceridine (TRV130) was designed to optimize mu opioid receptor pharmacology to deliver an improved analgesic profile, and has been granted Breakthrough Therapy designation by the U.S. Food & Drug Administration. Oliceridine is the first mu receptor G protein pathway selective modulator (muGPS) – a biased mu opioid receptor ligand that in preclinical studies activated pathways associated with analgesia while avoiding pathways that can promote respiratory depression and gastrointestinal dysfunction and limit analgesia. It is in Phase 3 development. In Phase 2, intravenous oliceridine demonstrated rapid and powerful analgesic efficacy with reduced frequency of opioid-related adverse events including nausea, vomiting, and hypoventilation compared to intravenous morphine. Trevena believes that oliceridine may offer an improved safety and tolerability profile compared to conventional opioid analgesics while providing powerful pain relief to patients. Trevena anticipates that the initial market opportunity for oliceridine will be in the acute care settings, with a focus on moderate to severe acute pain in the hospital.


Wow!! Simply incredible to get in at such a incredible price, and opportunity!!
This company is about to go BIG!!

GO TRVN!!